Records containing: Renal Cell Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-09-21A Phase I Study of Bevacizumab and Escalation Doses of BKM-120 in Patients With Metastatic Renal Cell Carcinoma Who Failed Prior Systemic Therapies
-
CLINICAL_TRIALS study record update · 2016-09-01A Phase II Study of Combinations of Dendritic Cells and Cytokine-induced Killer Cell （D-CIK) Immunotherapy And Anti-Programmed Death-1 In Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2016-08-10A Phase II, Open-Label, Randomized Study of GDC-0980 Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following VEGF-Targeted Therapy
-
CLINICAL_TRIALS study record update · 2016-07-29Comparison of Peri-operative Outcomes of Laparoscopic or Robotic Partial Nephrectomy for Small Renal Mass: Transperitoneal vs Retroperitoneal Approach
-
CLINICAL_TRIALS study record update · 2016-07-27A Pilot Study of Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma Undergoing Definitive Therapy With Radical Nephrectomy, or Cytoreductive Nephrectomy: Analysis if Serum and Tissue Biomarkers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-06-28An Open-label, Multicenter Phase II Study to Compare the Efficacy and Safety of RAD001 as First-line Followed by Second-line Sunitinib Versus Sunitinib as First-line Followed by Second-line RAD001 in the Treatment of Patients With Metastatic Renal Cell Carcinoma.
-
CLINICAL_TRIALS study record update · 2016-06-02DC1s-CTL Cell Therapy to Treat Patients With Renal Cell Carcinoma After Radical Resection
-
CLINICAL_TRIALS study record update · 2016-04-15A Phase 1, Open-Label, Multicenter, Multidose, Dose Escalation Study of BMS-936558 (Nivolumab) in Subjects With Selected Advanced or Recurrent Malignancies
-
CLINICAL_TRIALS study record update · 2016-03-25A Phase 1 First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 172 in Subjects With Relapsed / Refractory Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2016-03-24Phase II, Randomized Trial of Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2016-03-08The Comparison of Accuracy of Contrast Enhanced Ultrasound on Diagnosis of Small Renal Masses and Distinguishing Renal Cell Carcinomas From Other Renal Masses, With Biopsy
-
CLINICAL_TRIALS study record update · 2016-03-03CT Metrology: Quantitative Imaging Metrics With Advanced Visualization Tools for Cancer Imaging
-
CLINICAL_TRIALS study record update · 2016-03-03CASE 10813: A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2016-02-25A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients
-
CLINICAL_TRIALS study record update · 2016-02-22Safety and Therapeutic Efficacy of DC Vaccine Combined With Cytokine-induced Killer Cells in Patients With Renal Cell Carcinoma: a Phase I/II Study
-
CLINICAL_TRIALS study record update · 2016-01-20A Multi-Center, Open-Label, Single-Arm, Phase 2 Study of ASONEP™ (Sonepcizumab/LT1009) Administered as a Single Agent to Subjects With Refractory Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2015-12-21Low Intensity Allogeneic Hematopoietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma Using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells
-
CLINICAL_TRIALS study record update · 2015-12-10The Effect of Remote Ischemic Preconditioning in Partial Nephrectomy
-
CLINICAL_TRIALS study record update · 2015-12-09A Phase II, Single Arm, Prospective Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2015-12-09Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy
-
CLINICAL_TRIALS study record update · 2015-12-03A Phase I Dose Escalation Study of JX-594 (Thymidine Kinase-deleted Vaccinia Virus Plus GM-CSF) Administered by Intravenous Infusion in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-10-30The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2015-10-20A Randomized, Blinded, Phase 2 Dose-Ranging Study Of BMS-936558 (MDX-1106) In Subjects With Progressive, Advanced/Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
-
CLINICAL_TRIALS study record update · 2015-08-03An Open-label, Fixed-dose, Clinical Study of Quinacrine Safety and Efficacy in the Treatment of Advanced Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2015-07-23A Phase I/II Study of Sorafenib and Palliative Radiotherapy in Patients With Advanced Renal Cell Carcinoma and Symptomatic Bony Metastases